163 related articles for article (PubMed ID: 19891123)
1. Optimizing utilization of targeted therapies in genitourinary cancers.
Bukowski RM
Clin Genitourin Cancer; 2008 Dec; 6 Suppl 1():S6. PubMed ID: 19891123
[No Abstract] [Full Text] [Related]
2. Genitourinary malignancies.
Michaelson MD; Smith MR
Cancer Chemother Biol Response Modif; 2003; 21():547-64. PubMed ID: 15338763
[No Abstract] [Full Text] [Related]
3. Role of multidrug resistance in tumors of the genitourinary tract.
Theyer G; Hamilton G
Urology; 1994 Dec; 44(6):942-50. PubMed ID: 7985331
[No Abstract] [Full Text] [Related]
4. Genitourinary cancer.
Hudes GR; Ozols RF; Schilder RJ
Cancer Chemother Biol Response Modif; 1991; 12():509-48. PubMed ID: 1718377
[No Abstract] [Full Text] [Related]
5. Management of advanced genitourinary tumors.
Pietrantonio F; Biondani P; Verzoni E; Procopio G
Tumori; 2012; 98(2):264-6. PubMed ID: 22677995
[TBL] [Abstract][Full Text] [Related]
6. Gemcitabine, paclitaxel, pemetrexed and other newer agents in urothelial and kidney cancers.
Sternberg CN; Vogelzang NJ
Crit Rev Oncol Hematol; 2003 Jun; 46 Suppl():S105-15. PubMed ID: 12850531
[TBL] [Abstract][Full Text] [Related]
7. Feasibility and activity for sequencing targeted therapies for the treatment of advanced renal cell carcinoma.
Procopio G; Verzoni E; Bajetta E
Med Oncol; 2010 Dec; 27(4):1267-8. PubMed ID: 19957113
[No Abstract] [Full Text] [Related]
8. A review of therapeutic strategies for phase I-II trials in genitourinary cancer.
Friedman MA
Recent Results Cancer Res; 1980; 70():203-10. PubMed ID: 7188814
[No Abstract] [Full Text] [Related]
9. Chemotherapy of renal cell carcinoma: 1983-1989.
Yagoda A
Semin Urol; 1989 Nov; 7(4):199-206. PubMed ID: 2694257
[No Abstract] [Full Text] [Related]
10. [ I.Renal cell carcinoma].
Tomita Y
Gan To Kagaku Ryoho; 2014 Jan; 41(1):38-41. PubMed ID: 24796020
[No Abstract] [Full Text] [Related]
11. Optimizing treatment for metastatic renal cell carcinoma.
Patard JJ; Porta C; Wagstaff J; Gschwend JE
Expert Rev Anticancer Ther; 2011 Dec; 11(12):1901-11. PubMed ID: 22117157
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of a drug sensitivity test using fosfomycin on human urogenital cancers transplanted subcutaneously in nude mice].
Murahashi I; Hosoya Y; Mukae K; Honda M; Takasaki E
Gan To Kagaku Ryoho; 1991 Jan; 18(1):127-9. PubMed ID: 1987894
[No Abstract] [Full Text] [Related]
13. Sunitinib for metastatic renal cell carcinoma.
Mukherji D; Larkin J; Pickering L
Future Oncol; 2010 Sep; 6(9):1377-85. PubMed ID: 20919823
[TBL] [Abstract][Full Text] [Related]
14. UK guidelines for the systemic treatment of renal cell carcinoma.
Nathan P; Wagstaff J; Porfiri E; Powles T; Eisen T
Br J Hosp Med (Lond); 2009 May; 70(5):284-6. PubMed ID: 19451873
[TBL] [Abstract][Full Text] [Related]
15. Sunitinib in renal-cell carcinoma: expanded indications.
Choueiri TK; Bellmunt J
Lancet Oncol; 2009 Aug; 10(8):740. PubMed ID: 19615941
[No Abstract] [Full Text] [Related]
16. Another step toward the cure of metastatic renal cell carcinoma?
Vogelzang NJ
J Clin Oncol; 2010 Dec; 28(34):5017-9. PubMed ID: 20975069
[No Abstract] [Full Text] [Related]
17. [III. Topics of chemotherapy].
Murakami Y; Eto M
Gan To Kagaku Ryoho; 2015 Jan; 42(1):36-40. PubMed ID: 25920099
[No Abstract] [Full Text] [Related]
18. What is new in kidney cancer?
Kirkali Z
Expert Rev Anticancer Ther; 2009 Dec; 9(12):1753-5. PubMed ID: 19954286
[TBL] [Abstract][Full Text] [Related]
19. Circadian chemotherapy for gynecological and genitourinary cancers.
Kobayashi M; Wood PA; Hrushesky WJ
Chronobiol Int; 2002 Jan; 19(1):237-51. PubMed ID: 11962679
[TBL] [Abstract][Full Text] [Related]
20. New perspectives in advanced genitourinary malignancies.
Biondani P; Procopio G; Pietrantonio F; de Braud F; Verzoni E
Tumori; 2012; 98(2):267-9. PubMed ID: 22677996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
